carmot-therapeutics.usHealthcareFounded: 2008Funding to Date: $222.31MM
Carmot Therapeutics is focused on the discovery and development of disease-modifying therapies for patients living with metabolic diseases and cancer. Carmot applies Chemotype Evolution (CE), a pioneering drug discovery platform, in combination with unique biological expertise to identify innovative and superior therapeutics.
View Enterprise Value for Carmot Therapeutics.